COVID-KOSHA
Home
Help
(current)
Comment
!
Note: Language translations may be imperfect
A model anti-pandemic portal for scientists & public
;
High priority articles (R1, Most articles most likely to be relevant):
Second priority articles (R2, Moderate portion of articles likely to be relevant):
Other articles (R3, Lesser portion of articles likely to be relevant):
Auto Summaries -
Drug
Last updated: 2024 Nov 18
Total hit(s): 6799
S.No.
PMID
Ascending order
Descending order
Title
Ascending order
Descending order
Auto Summary
Ascending order
Descending order
Journal Name
Ascending order
Descending order
Publish Date
Ascending order
Descending order
Impact Factor
Ascending order
Descending order
Citations
Ascending order
Descending order
1
39522531
Impact of JN.1 booster vaccination on neutralisation of SARS-CoV-2 variants KP.3.1.1 and XEC.
N/A
Lancet Infect Dis
2024 Nov 7
21.77
1
2
39447388
Corrigendum to "Middle East respiratory syndrome coronavirus-a 10-year (2012-2022) global analysis of human and camel infections, genomic sequences, lineages, and geographical origins" [International Journal of Infectious Diseases (2023), volume 131, 87-94].
N/A
Int J Infect Dis
2024 Oct 23
3.42
1
3
39321502
Corrigendum to "The significance of recurrent de novo amino acid substitutions that emerged during chronic SARS-CoV-2 infection: an observational study" [eBioMedicine, 2024;107:105273].
N/A
EBioMedicine
2024 Oct
6.49
1
4
39341219
Humoral immunity after mRNA SARS-CoV-2 omicron JN.1 vaccination.
N/A
Lancet Infect Dis
2024 Sep 25
21.77
1
5
39164256
Immune recall enhances cross-reactive antibody longevity after a large wave of SARS-CoV-2 breakthrough infection.
N/A
Signal Transduct Target Ther
2024 Aug 21
- n/a -
1
6
38980939
Impact of coronavirus disease 2019 monoclonal antibodies on outcomes of coronavirus disease 2019 infection in hematopoietic stem cell transplant and chimeric antigen receptor therapy recipients.
N/A
Transpl Infect Dis
2024 Jul 9
2.04
1
7
39083043
Features of the SARS-CoV-2 KP.3 variant mutations.
N/A
Infect Dis (Lond)
2024 Jul 31
1.23
1
8
38961696
Is there an increased number of community-acquired pneumonia requiring drainage placement in children after COVID-19 pandemic in Italy?
N/A
Pediatr Pulmonol
2024 Jul 3
2.64
1
9
39002189
Design and fabrication strategies of molybdenum disulfide-based nanomaterials for combating SARS-CoV-2 and other respiratory diseases: A review.
N/A
Biomater Adv
2024 Jul 3
1
10
39041943
Validating combination throat-nasal swabs for COVID-19 tests would improve early detection, especially for the most vulnerable.
N/A
Clin Infect Dis
2024 Jul 23
7.71
1
11
39041264
Unveiling the Role of SARS-CoV-2 or mRNA Vaccine Spike Protein in Macrophage Activation Syndrome (MAS).
N/A
Infect Disord Drug Targets
2024 Jul 22
1.5
1
12
39030295
Deletion of V483 in the spike confers evolutionary advantage on SARS-CoV-2 for human adaptation and host-range expansion after a prolonged pandemic.
N/A
Cell Res
2024 Jul 19
10.9
1
13
38809158
Another variant another history: description of the SARS-CoV-2 KP.2 (JN.1.11.1.2) mutations.
N/A
Infect Dis (Lond)
2024 Jul
1.23
1
14
38937220
A case of generalized pustular psoriasis following Moderna/NIAID COVID-19 vaccination successfully treated with secukinumab.
N/A
An Bras Dermatol
2024 Jun 26
1
15
38960856
The experience of pregnant women and their families who were infected with covid-19 before vaccination: Comment.
N/A
Midwifery
2024 Jun 21
4.3
1
16
38734020
Additional SARS-CoV-2 vaccine doses: a little is better than none.
N/A
Lancet Rheumatol
2024 May 8
- n/a -
1
17
38713760
Correction to "Exploration of SARS-CoV-2 3CL(pro) Inhibitors by Virtual Screening Methods, FRET Detection, and CPE Assay".
N/A
J Chem Inf Model
2024 May 7
4.04
1
18
38803053
Active vitamin D analog and SARS-CoV-2 IgG after BNT162b2 vaccination in patients with hemodialysis: Correspondence.
N/A
Ther Apher Dial
2024 May 27
2.7
1
19
38664266
Correction: Detection of SARS-CoV-2 spike protein D614G mutation using muTGGE.
N/A
Mol Biol Rep
2024 Apr 25
2.19
1
20
38607273
The mouse to man conundrum: Revisiting an old lung injury model to study repurposed drugs for COVID-19 treatment.
N/A
Exp Physiol
2024 Apr 12
4.3
1
21
38511965
Erratum for Karaba et al., "Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment".
N/A
mBio
2024 Apr 10
6.5
1
22
38272241
N/A
2024 Apr
1
23
38335905
Convalescent plasma: An unexpected new therapeutic option for critically ill COVID-19 patients coming from the past.
N/A
J Clin Anesth
2024 Feb 8
2.74
1
24
38310906
Persistence of immune responses of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2.
N/A
Lancet Infect Dis
2024 Feb 1
21.77
1
25
38048665
Fixation and reversion of mutations in the receptor-binding domain of SARS-CoV-2 spike protein.
N/A
Diagn Microbiol Infect Dis
2024 Feb
2.33
1